Zilokem 40 Tablet contains Azilsartan medoxomil 40 mg, an angiotensin II receptor blocker (ARB) used primarily for the management of hypertension. Azilsartan medoxomil works by selectively inhibiting the binding of angiotensin II to the AT1 receptor subtype found in vascular smooth muscle, thereby preventing vasoconstriction and the release of aldosterone. This leads to vasodilation, reduced peripheral resistance, and ultimately a decrease in blood pressure. Zilokem 40 is indicated for the treatment of essential hypertension to reduce the risk of cardiovascular events such as stroke and myocardial infarction. The tablet is administered orally, typically once daily, with or without food. It is generally well tolerated, with common adverse effects including dizziness, fatigue, and gastrointestinal disturbances. Caution is advised in patients with impaired renal or hepatic function, and it is contraindicated in pregnancy due to potential fetal toxicity. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Zilokem 40 should be used as part of a comprehensive treatment plan including lifestyle modifications such as diet and exercise to achieve optimal blood pressure control.